by Michael Cannon, CATO Institute
From the Washington Post:
Hedge fund executives and other investors are increasingly interested in the timing and nature of health-policy decisions in Washington because they directly affect the profits and stock prices of pharmaceutical, insurance, hospital and managed-care companies…
[Former Centers for Medicare & Medicaid Services] director Thomas Scully, who served during the Bush administration…said he thought that it was useful for CMS officials to have more communication with Wall Street investors as a way for regulators to learn and “explain what an $800-billion-a-year agency” does with its money.
So long as someone is still making a buck, it’s not socialized medicine…right?
Latest posts by TAC Daily Updates (see all)
- FDA Bureaucracy Blocks ‘Miracle Drug’ from 7-Year-Old - October 27, 2016
- Iceland Today, the US Tomorrow? - October 17, 2016
- Understanding the “General Good” Through a Lockean Lens - October 7, 2016